Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice

Farooq Syed(Indiana University – Purdue University Indianapolis), Carmella Evans‐Molina(Richard L. Roudebush VA Medical Center), Stéphane Demine(Indiana Biosciences Research Institute), Eugenia Martin Vázquez(Université Libre de Bruxelles), Preethi Krishnan(Indiana University – Purdue University Indianapolis), Kara S. Orr(Indiana University – Purdue University Indianapolis), Maria Inês Alvelos(Université Libre de Bruxelles), Ângela Castela(Université Libre de Bruxelles), Alexandra Coomans de Brachène(Université Libre de Bruxelles), Arnaud Zaldumbide(Leiden University Medical Center), Lorella Marselli(University of Pisa), Staci A. Weaver(Indianapolis Zoo), Décio L. Eizirik(Université Libre de Bruxelles), Sofia Thomaidou, Donalyn Scheuner(Indiana Biosciences Research Institute), John S. Kaddis(City of Hope), Jing Liu(Liaoning University of Traditional Chinese Medicine), Garrick Chang(Indiana University Indianapolis), Jyoti Rana(Indiana University – Purdue University Indianapolis), Olivia Ballew(Indiana Biosciences Research Institute), Namratha Shivani Chalasani(Indiana University School of Medicine), Piero Marchetti(University of Pisa), Chih‐Chun Lee(Diabetes Australia), Jamie L. Felton(University School)
EBioMedicine
May 6, 2025
Cited by 14


Related Papers